Literature DB >> 14803552

The mechanism of hemolysis in paroxysmal cold hemoglobinuria. I. The role of complement and its components in the Donath-Landsteiner reaction.

W S JORDAN, L PILLEMER, J H DINGLE.   

Abstract

Entities:  

Keywords:  HEMOGLOBINURIA PAROXYSMAL; HEMOLYSIS

Mesh:

Substances:

Year:  1951        PMID: 14803552      PMCID: PMC436222          DOI: 10.1172/JCI102410

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  4 in total

1.  OBSERVATIONS ON PAROXYSMAL HEMOGLOBINURIA.

Authors:  G M Mackenzie; E Frühbauer
Journal:  J Clin Invest       Date:  1929-04       Impact factor: 14.808

2.  THE TERMINOLOGY OF THE COMPONENTS OF COMPLEMENT.

Authors:  L Pillemer; E E Ecker
Journal:  Science       Date:  1941-11-07       Impact factor: 47.728

3.  The mechanism of hemolysis in paroxysmal cold hemoglobinuria. II. Observations on the behavior and nature of the antibody.

Authors:  W S JORDAN; L PILLEMER; J H DINGLE
Journal:  J Clin Invest       Date:  1951-01       Impact factor: 14.808

4.  A New Antibody in Serum of Patients With Acquired Hemolytic Anemia.

Authors:  P Sturgeon
Journal:  Science       Date:  1947-09-26       Impact factor: 47.728

  4 in total
  4 in total

1.  The haemolytic activity of cold antibodies.

Authors:  J V DACIE
Journal:  Proc R Soc Med       Date:  1955-03

2.  [Serological peculiarities of unspecific acid cold hemolysins].

Authors:  H SCHUBOTHE
Journal:  Klin Wochenschr       Date:  1953-09-01

3.  The mechanism of hemolysis in paroxysmal cold hemoglobinuria. II. Observations on the behavior and nature of the antibody.

Authors:  W S JORDAN; L PILLEMER; J H DINGLE
Journal:  J Clin Invest       Date:  1951-01       Impact factor: 14.808

4.  STUDIES ON IMMUNE HUMAN HEMOLYSIS : II. THE DONATH-LANDSTEINER REACTION AS A MODEL SYSTEM FOR STUDYING THE MECHANISM OF ACTION OF COMPLEMENT AND THE ROLE OF C'1 AND C'1 ESTERASE.

Authors:  C F Hinz; M E Picken; I H Lepow
Journal:  J Exp Med       Date:  1961-01-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.